Mercer Global Advisors
MGRX icon

Mercer Global Advisors’s Mangoceuticals MGRX Stock Holding History

Mercer Global Advisors’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,667
Closed -$30.4K – 2018
2024
Q2 		$30.4K Hold
6,667
– – ﹤0.01% 1933
2024
Q1 		$22K Buy
+6,667
New +$26.5K ﹤0.01% 1917

Other funds holding MGRX

ACA
Ackerman Capital Advisors Dallas, Texas $488M AUM 14.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Mercer Global Advisors's MGRX Position: Q3 2024 in Review

Mercer Global Advisors sold out of Mangoceuticals (MGRX) in Q3 2024, closing a stake of 6,667 shares — an estimated $30.4K sold.

Mercer Global Advisors first reported a position in MGRX in Q1 2024 and held it in 2 quarters. The position peaked at $30.4K in Q2 2024. 13 funds tracked by Wall St. Rank hold MGRX as of Q3 2024.

  • Mercer Global Advisors reported no remaining Mangoceuticals position as of Q3 2024 after selling out during the quarter.
  • Mercer Global Advisors sold 6,667 Mangoceuticals shares in Q3 2024, an estimated $30.4K.
  • Mercer Global Advisors first reported a position in Mangoceuticals in Q1 2024 and held it in 2 quarters.
  • Mercer Global Advisors's Mangoceuticals position peaked at $30.4K in Q2 2024.
  • 13 funds tracked by Wall St. Rank held Mangoceuticals as of Q3 2024.

Based on Mercer Global Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.